Labetalol Hydrochloride Tablet, Film Coated
Product Images NDC 70771-1165

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 70771-1165). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Labetalol Hydrochloride Tablets (Ff56a8ca 43a3 484a B91a C6ef13d9810a 02)

The text seems to be a label of medication with the name Labetalol BRI Hydrochloride Pt Tablets, USP. The package contains 30 tablets and was manufactured by Roonly. The NDC number is 70771-116 and instructions advise to keep it in a cool place.*

FDA Label Image

Labetalol Hydrochloride Tablets (Ff56a8ca 43a3 484a B91a C6ef13d9810a 03)

Each tablet of this medication contains Labetalol Hydrochloride. The tablets are coated with fim and are USP standard. This medication is manufactured and distributed by a healthcare company and comes in bottles of 30 tablets. This medication is only available with a prescription. Keep all drugs out of reach.*

FDA Label Image

Labetalol Hydrochloride Tablets (Ff56a8ca 43a3 484a B91a C6ef13d9810a 04)

This appears to be a description of a medication called Labetalol Hydrochloride, which is available in the form of 300 mg tablets. The text also includes a warning to keep the drug out of reach of children. However, there is no additional information available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.